Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
DCC, A Dublin-based and London Stock Exchange-listed sales, marketing and support services group, has announced it has entered into a definitive agreement to sell its healthcare division to HealthCo, an investment vehicle of funds managed by European private equity firm Investindustrial Advisors, for £1.05 billion (approximately €1.23 billion).
A few weeks ago, I went to check out four Korean medtech startups in central London demonstrating their innovative solutions amid the UK’s growing senior healthcare crisis. Each startup addressed a challenge in elderly care, including fall prevention (with prevention being called for more generally in the UK health system too), medication adherence, dementia diagnosis, and air quality monitoring.
Healthtech was the strongest sector for investment in the first quarter of 2025 in the UK, with startups receiving $1.8bn, according to an HSBC report.
Apple is reportedly developing a new AI doctor service in its biggest healthcare push to date. The company is working on ‘Project Mulberry’, which involves an entirely revamped Health app plus a health coach, according to Bloomberg. The service would be powered by a new AI agent intended to replicate, where possible, a real doctor.
Asker Healthcare Group, the pan-European medical products and solutions provider, has announced its intention to launch an initial public offering (IPO) and to list its shares on Nasdaq Stockholm.
Unicorn femtech Flo Health, a period tracker, ovulation tracker and pregnancy app, is looking for startups to acquire to help expand into new health verticals and increase revenue following a $200 million raise from US investor General Atlantic in August.
naturalX Health Ventures, a venture capital fund backed by Schwabe Group, a plant-based pharmaceutical group, has announced a €100 million fund to accelerate the consumer health revolution in Europe.
Gerresheimer AG, a German maker of packaging for drugs and cosmetics, has confirmed it is in discussions with private equity investors about a potential takeover offer.
The US-based med tech giant GE HealthCare is investing $138 million to expand its contrast media manufacturing site in Cork.
Iodinated contrast media (ICM) are injectable diagnostic agents which enhance the visibility of organs, blood vessels, and tissues during X-rays and CT scans, playing a key role in diagnosing conditions like cancer and heart disease.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.